155
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Elevated Thyroid Stimulating Hormone with Atherosclerotic Cardiovascular Disease and Its Mortality in Elderly Community-Dwelling Chinese

, , , , , , , , , ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 1139-1150 | Published online: 13 Nov 2023

References

  • Liyuan M, Yazhe W, Wen W, Weiwei C. Interpretation of the report on cardiovascular diseases in China (2017). Chin J Cardiol. 2018;23(1):3–6.
  • Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586. doi:10.1161/CIRCULATIONAHA.109.192703
  • Kochanek KD, Murphy S, Xu J. Arias EJNdb. Mortality U S. 2016;2017(293):1–8.
  • Hollowell J, Serum TSH, Flanders WD. T4, and Thyroid Antibodies in the United States Population (1988 to 1994): national health and nutrition examination survey (NHANES III). J Clin Endocr Metabolism. 2002;87:489–499. doi:10.1210/jcem.87.2.8182
  • Cappola AR, Fried LP, Arnold AM, et al. Thyroid Status. Cardiol Risk Mortality Older Adults. 2006;295(9):1033–1041.
  • Boelaert K; Boelaert, and Kristien. Thyroid dysfunction in the elderly. Nat Rev Endocrinol. 2013;9:194–204. doi:10.1038/nrendo.2013.30
  • Baloch Z, Carayon P, Conte-Devolx B, Demers LM. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3–126. doi:10.1089/105072503321086962
  • Sue W, Parle JV, Roberts LM, et al. Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. J Clin Endocr Metabolism. 2006;91(12):4809–4816. doi:10.1210/jc.2006-1557
  • Ruggeri RM, Trimarchi F, Biondi B. Management Of Endocrine Disease: l-Thyroxine replacement therapy in the frail elderly: a challenge in clinical practice. Eur J Endocrinol. 2017;177(4):R199–R217. doi:10.1530/EJE-17-0321
  • Floriani C, Gencer B, Collet TH, Rodondi N. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J. 2018;39(7):7.
  • Ochs N, Auer R, Bauer DC, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148(11):832–845. doi:10.7326/0003-4819-148-11-200806030-00225
  • Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005;165(21):2467–2472. doi:10.1001/archinte.165.21.2467
  • Razvi S, Pearce SH. Subclinical hypothyroidism and cardiovascular disease-reply. Arch Intern Med. 2012;172(19):1523–1524. doi:10.1001/2013.jamainternmed.597
  • Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365–1374. doi:10.1001/jama.2010.1361
  • Jones DD, May KE, Geraci S. Subclinical thyroid disease. Lancet. 2012;123(6):502–504.
  • Razvi S, Weaver JU, Vanderpump MP, Pearce SHS. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the whickham survey cohort. J Clin Endocr. 2010;95(4):1734–1740. doi:10.1210/jc.2009-1749
  • Misa I, Masazumi A, Shinichiro I, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004;89(7):3365–3370.
  • Selmer C, Olesen JB, Hansen ML, et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocr. 2014;99(7):2372–2382. doi:10.1210/jc.2013-4184
  • Gussekloo J. Thyroid status, disability and cognitive function, and survival in old age. J Am Med Assoc. 2005;292(21):2591–2599. doi:10.1001/jama.292.21.2591
  • Zhai XD, Zhang L, Chen LL, et al. An age-specific serum thyrotropin reference range for the diagnosis of thyroid diseases in older adults: a cross-sectional survey in China. Thyroid. 2018;28(12):1571–1579. doi:10.1089/thy.2017.0715
  • Brosius FC, Hostetter TH, Kelepouris E, et al. REPRINT Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease. Hypertension. 2006;48(4):751–755. doi:10.1161/CIRCULATIONAHA.106.177321
  • Juonala M, Magnussen CG, Berenson GS, Venn A. Childhood adiposity, adult adiposity, and cardiovascular risk factors. NEJM. 2011;365(20):1876. doi:10.1056/NEJMoa1010112
  • Wu YF, Zhao D, Zhou BF, et al. Cut offs and risk stratification of dyslipidemia in Chinese adults. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35(5):428.
  • Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease. J Am Coll Cardiol. 2019;74(10):e177–e232. doi:10.1016/j.jacc.2019.03.010
  • Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132(17):1667. doi:10.1161/CIRCULATIONAHA.114.008720
  • Silva N, Santos O, Morais F, et al. Subclinical hypothyroidism represents an additional risk factor for coronary artery calcification, especially in subjects with intermediate and high cardiovascular risk scores. Eur J Endocrinol. 2014;171(3):327–334. doi:10.1530/EJE-14-0031
  • Stratigou T, Dalamaga M, Antonakos G, et al. Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors. Endocrine. 2018;61(1):83–93. doi:10.1007/s12020-018-1550-3
  • Wu J, Tao Y, Gu H, Sui J. Association between cardiovascular risk factors and serum thyrotropin concentration among healthy Chinese subjects and subjects with unsuspected subclinical hypothyroidism. Clin Lab. 2016;62(5):807–814. doi:10.7754/Clin.Lab.2015.150809
  • Asvold BO, Bjøro T, Nilsen TI, Vatten LJ. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. J Clin Endocr Metabolism. 2007;92(3):841–845. doi:10.1210/jc.2006-2208
  • Bielecka-Dabrowa A, Godoy B, Suzuki T, Banach M, von Haehling S. Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function. Clin Res Cardiol. 2019;108(3):225–233. doi:10.1007/s00392-018-1340-1
  • Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:257–268.
  • Haghi AR, Solhjoo M, Tavakoli MH. Correlation between subclinical hypothyroidism and dyslipidemia. Iran J Pathol. 2017;12(2):106–111.
  • Bensenor IM, Olmos RD, Lotufo PA. Hypothyroidism in the elderly: diagnosis and management. Clin Interv Aging. 2012;7:97–111. doi:10.2147/CIA.S23966
  • Pearce SH, Razvi S, Yadegarfar ME, et al. Serum thyroid function, mortality and disability in advanced old age: the Newcastle 85+ Study. J Clin Endocrinol Metab. 2016;101(11):4385–4394. doi:10.1210/jc.2016-1935
  • Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol. 2008;125(1):41–48. doi:10.1016/j.ijcard.2007.02.027
  • Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 2010;43(1):55–68.
  • McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C, Hoogwerf BJ. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid. 2011;21(8):837–843. doi:10.1089/thy.2010.0298
  • Moon S, Kim MJ, Yu JM, Yoo HJ, Park YJ. Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Thyroid. 2018;28(9):1101–1110. doi:10.1089/thy.2017.0414
  • Yang L-B, Jiang D-Q, Qi W-B, et al. Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies. Eur J Endocrinol. 2012;167(1):75–84. doi:10.1530/EJE-12-0015
  • Silva JE. Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid. 2008;18(2):157–165.
  • Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the U.S. population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007;92(12):4575–4582. doi:10.1210/jc.2007-1499
  • Somwaru LL, Rariy CM, Arnold AM, Cappola AR. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocr. 2012;97(6):1962–1969. doi:10.1210/jc.2011-3047
  • Lindeman RD, Romero LJ, Schade DS, Wayne S, Baumgartner RN, Garry P. Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the new mexico elder health survey. Thyroid. 2003;13(6):595–600. doi:10.1089/105072503322238863
  • Svold BO, Bjro T, Platou C, Vatten L. Thyroid function and the risk of coronary heart disease: 12‐year follow‐up of the HUNT Study in Norway. Clin Endocrinol. 2012;77:6.